Raymond James Financial’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63K Buy
69,380
+40,009
+136% +$36.3K ﹤0.01% 5033
2025
Q1
$13.3K Sell
29,371
-5,000
-15% -$2.26K ﹤0.01% 4700
2024
Q4
$17.3K Buy
+34,371
New +$17.3K ﹤0.01% 4678